20 insiders reported 93 Form 4 transactions for MoonLake Immunotherapeutics (MLTX) over the past 18 months (most recent 2026-07-02). Recent activity: Santos da Silva Jorge (Chief Executive Officer) Sell 47,775 shares, Bodenstedt Matthias (Chief Financial Officer) Sell 39,120 shares, Bodenstedt Matthias (Chief Financial Officer) Sell 15,082 shares, Bodenstedt Matthias (Chief Financial Officer) Sell 2,794 shares, Reich Kristian (Chief Scientific Officer) Sell 50,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Santos da Silva Jorge | Chief Executive Officer | Sell | 47,775 | $956,933 |
| 2026-06-23 | Bodenstedt Matthias | Chief Financial Officer | Sell | 39,120 | $862,205 |
| 2026-06-18 | Bodenstedt Matthias | Chief Financial Officer | Sell | 15,082 | $296,814 |
| 2026-06-18 | Bodenstedt Matthias | Chief Financial Officer | Sell | 2,794 | $54,762 |
| 2026-06-17 | Reich Kristian | Chief Scientific Officer | Sell | 50,000 | $944,500 |
| 2026-06-17 | Reich Kristian | Chief Scientific Officer | Sell | 50,000 | $935,000 |
| 2026-06-17 | Reich Kristian | Chief Scientific Officer | Sell | 50,000 | $971,500 |
| 2026-05-13 | Bodenstedt Matthias | Chief Financial Officer | Sell | 13,653 | $273,333 |
| 2026-04-16 | Bodenstedt Matthias | Chief Financial Officer | Sell | 2,426 | $47,453 |
| 2026-04-14 | Santos da Silva Jorge | Chief Executive Officer | Sell | 98,127 | $1.8M |
| 2026-04-14 | Santos da Silva Jorge | Chief Executive Officer | Sell | 51,873 | $945,645 |
| 2026-04-10 | Bodenstedt Matthias | Chief Financial Officer | Sell | 1,925 | $37,557 |
| 2026-04-10 | Bodenstedt Matthias | Chief Financial Officer | Sell | 85,870 | $1.6M |
| 2026-04-02 | BVF PARTNERS L P/IL | Director | Sell | 1.9M | $32.4M |
| 2026-04-02 | LAMPERT MARK N | Director | Sell | 1.9M | $32.4M |
| 2026-04-02 | BVF INC/IL | Director | Sell | 1.9M | $32.4M |
| 2026-04-02 | Biotechnology Value Trading Fund OS LP | Director | Sell | 1.9M | $32.4M |
| 2026-04-02 | BVF Partners OS Ltd. | Director | Sell | 1.9M | $32.4M |
| 2026-04-02 | BVF I GP LLC | Director | Sell | 1.9M | $32.4M |
| 2026-04-02 | BIOTECHNOLOGY VALUE FUND II LP | Director | Sell | 1.9M | $32.4M |
| 2026-04-02 | BVF II GP LLC | Director | Sell | 1.9M | $32.4M |
| 2026-04-02 | BIOTECHNOLOGY VALUE FUND L P | Director | Sell | 1.9M | $32.4M |
| 2026-04-02 | BVF GP HOLDINGS LLC | Director | Sell | 1.9M | $32.4M |
| 2026-04-02 | BVF GP HOLDINGS LLC | Director | Sell | 1.6M | $26.3M |
| 2026-04-02 | BVF PARTNERS L P/IL | Director | Sell | 1.6M | $26.3M |
Source: SEC Form 4 filings · as of 2026-07-02